Cardiac resynchronization therapy for heart failure

A Ojo, S Tariq, P Harikrishnan, S Iwai… - Interv Cardiol …, 2017 - books.google.com
Guideline-directed medical therapy, such as angiotensin-converting enzyme inhibitors, beta
blockers, and spironolactone have improved symptoms and survival in patients with …

[PDF][PDF] Resynchronization therapy for heart failure

LA Saxon, T De Marco, LW Stevenson… - Accessed …, 2005 - blakewachter.com
Heart failure (HF) is a clinical syndrome comprised of symptoms and signs associated with
congestion and/or hypoperfusion. It can result from any structural or functional cardiac …

Cardiac resynchronization therapy for mild heart failure: the time has come

CR Reynolds, MR Gold - Circulation, 2011 - Am Heart Assoc
195 all-cause mortality did not differ significantly between groups (HR, 0.73; 95% CI, 0.34 to
1.54). In the Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure …

Cardiac resynchronization therapy in heart failure patients: tough road but clear future

Z Wang, Y Wu, J Zhang - Heart Failure Reviews, 2021 - Springer
Cardiac resynchronization therapy (CRT) based on biventricular pacing (BVP) is an
invaluable intervention currently used in heart failure (HF) patients. The therapy involves …

[HTML][HTML] Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: lessons from the Multicenter InSync …

C Linde, AB Curtis, GC Fonarow, K Lee, W Little… - International Journal of …, 2016 - Elsevier
Background The benefits of CRT for symptomatic heart failure (HF) patients with a wide QRS
and reduced left ventricular ejection fraction (LVEF≤ 35%), are well established. Post-hoc …

Cardiac resynchronization therapy in patients with New York Heart Association class I and II heart failure: an approach to 2010

C Linde, C Daubert - Circulation, 2010 - Am Heart Assoc
It has been firmly established that cardiac resynchronization therapy (CRT) reduces
symptoms and decreases morbidity and mortality1–6 in a subgroup of patients who remain …

Optimizing heart failure treatment following cardiac resynchronization therapy

A Jorsal, K Pryds, JJV McMurray, H Wiggers… - Clinical Research in …, 2020 - Springer
Background Device therapy in addition to medical treatment improves prognosis in a subset
of patients with heart failure and reduced ejection fraction. However, some patients remain …

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis

S Adabag, H Roukoz, IS Anand, AJ Moss - Journal of the American College …, 2011 - jacc.org
Objectives: The purpose of this study was to perform a systematic review and meta-analysis
of prospective randomized clinical trials of cardiac resynchronization therapy (CRT) versus …

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]

JGF Cleland, JC Daubert, E Erdmann… - European heart …, 2006 - academic.oup.com
Abstract Aims The CArdiac REsynchronization-Heart Failure study randomized patients with
left ventricular ejection fraction≤ 35%, markers of cardiac dyssynchrony, and persistent …

20 years of cardiac resynchronization therapy

F Leyva, S Nisam, A Auricchio - Journal of the American College of …, 2014 - jacc.org
Cardiac resynchronization therapy (CRT) is an accepted treatment for patients with heart
failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. It has been …